CSF2RA (Mavrilimumab Biosimilar) Antikörper
Kurzübersicht für CSF2RA (Mavrilimumab Biosimilar) Antikörper (ABIN7850141)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Anti-GM-CSFR(mavrilimumab biosimilar) mAb
-
Isotyp
- IgG4, P108S
-
-
-
-
Applikationshinweise
- Flow Cyt 1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.
-
-
- CSF2RA (Mavrilimumab Biosimilar)
-
Andere Bezeichnung
- mavrilimumab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
Synonyms Target:GM-CSF-R-alpha, GMCSFR-alpha, GMR-alpha, CDw116, CD116, CSF2RA, CSF2R, CSF2RY
Synonyms Antibody:CAM-3001
Target
-